Home Overview Press Room Blog Publications For Students about us
Search

Other News

Genetic Crossroads
April 30th, 2007

"Embryos to be screened for breast cancer gene," UK Daily Mail (April 26, 2007)
Two women are set to become the first to have their embryos screened for the faulty breast cancer gene to prevent their children from contracting the disease.

bullet Marcy Darnovsky and Susan Berke Fogel, "Oocyte Donation for Stem Cell Research," Science (April 20, 2007)
The scientific journal published a letter to the editor from CGS's Darnovsky and Fogel of the Pro-Choice Alliance for Responsible Research, on proposed international guidelines for stem cell research.

Peter Wonacott, "India's Skewed Sex Ratio Puts GE Sales in Spotlight," Wall Street Journal (April 18, 2007)
GE has waded into India's market as the country grapples with a difficult social issue: the abortion of female fetuses by families who want boys.

David Hamilton, "Is Big Pharma tiptoeing into embryonic stem cells?," Venture Beat (April 16, 2007)
For what appears to be the first time, a major drug company has plunked down a significant equity investment in embryonic stem cells.

Patricia J. Williams, "Colorstruck," The Nation (April 10, 2007)
"The lower half of the page was given over to a more lurid headline trumpeting 'a Park Avenue fertility clinic's blunder' that "left a family devastated - after a black baby was born to a Hispanic woman and her white husband."

Rachel Nowak, "Egg freezing: A reproductive revolution," New Scientist (March 21, 2007)
"Egg-freezing…in theory…could allow a woman to stop her biological clock for a decade or more....However, [it] is not being widely promoted for healthy women - in part, because fertility experts are in a quandary about which women should have access to it."

bullet Scott McCredie, "Designing Your Baby,"MSN (March 12, 2007)
The technology is in place to order up a child's physical traits or intellect. The issue is how far we want to take it.

bullet Kara Platoni, "The Gatekeeper,"East Bay Express (February 28, 2007)
What if scientists devised a strategy to tackle some of the world's most notorious diseases, but just one company held all the patents?


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760